维普中文期刊产品整合服务
85篇 您的检索式:作者名="UNGER JM"
    题名 作者 年代 出处 被引量
1Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma 显示文摘Stiff P J Unger JM Cook JR 2013N Engl J Med2013,369,18:1
2Vocal cord jinjection with autogenous fat:A long term magnetic resonance imaging evalulation 显示文摘Brandenburg JH Unger JM Kosechkee D 1996Laryngoscope1996,106,:1
3A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma;SWOG 0213显示文摘Bernstein SH Epner E Unger JM 2013Ann Oncol2013,24,:1
4A phaseⅡmulticenter trial of hyper CVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma;SWOG 0213显示文摘Bernstein SH Epner E Unger JM 2013Ann Oncol2013,24,6:1
5Underrepresentatin of patients 65 years of age or older in Cancer-treat- ment triMs显示文摘Hutchins LF Unger JM Crowley J J 1999N Engl J Med1999,341,:1
6Underrepresentation of patients 65 years of age or older in cancer-treatment trials显示文摘Hutchins LF Unger JM Crowley J J 1999N Engl J Med1999,341,:1
7Underrepresentation of pa- tients 65 years of age or older in cancer-treatment trials 显示文摘Hutchins LF Unger JM Crowley JJ 1999N Engl J Med1999,341,27:1
8Phase Ⅱ trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma:five-year follow-up of Southwest Oncology Group Protoco S9911显示文摘Press OW Unger JM Braziel RM 2006J Clin Oncol2006,24,25:1
9Protein Kinase CK2 as regulator of cell Survival: implications for cancer therapy 显示文摘Unger GM Davis AT Slaton JM 2004Curr Cancer Drug Targets2004,4,1:1
10Phase Ⅱ trial of CHOP chemotherapy followed by tositumomab/iedine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five- year follow-up of Southwest Oncology Group Protocol S9911 显示文摘Press OW Unger JM Braziel RM 2006J Clin Oncol2006,24,:1
11Phase Ⅱ trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five- year follow-up of Southwest Oncology Group Protocol S9911 显示文摘Press OW Unger JM Braziel RM 2006J Clin Oncol2006,24,25:1
12Distribution and origin of calcitonin gene- related peptide (CGRP) immunoreactivity in the sensory innervation of the mammalian eye 显示文摘Terenghi G Polak JM Ghatei MA Muiderry PK Butler JM Unger WG etal 1985J Comp Neurol1985,233,4:1
13A phase 2 trial of standard-dose eyelophosphamide, doxorubicin, vineristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515显示文摘Stopeck AT Unger JM Rimsza LM 2012Blood2012,120,6:1
14The oral cavity and tongue: magnetie resonance imaging显示文摘Unger JM 1985Radiology1985,155,1:1
15Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease显示文摘Legrand VM Serruys PW Unger F van Hout BA Vrolix MC Fransen GM Nielsen TT Paulsen PK Gomes RS de Queiroz e Melo JM Neves JP Lindeboom W Backx B Arterial Revascularization Therapy Study (ARTS) Investigators 2004Circulation2004,109,9:1
16The value of augmented prepara- tive regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: A South- west Oncology Group phase II trial显示文摘Stiff PJ Unger JM Forman S J 2003Biol Blood Marrow Trans- plant2003,9,8:1
17Natural history of CNS relapse in patients with aggressive non - Hodgkin's lymphoma: a 20 -year follow- up analysis of SWOG 8516 -Southwest Oncology Group显示文摘Bernstein SH Unger JM LeBlane M 2009J Clin Oncol2009,27,1:1
18Sphenoid fractures:prevalence,sites,and significance显示文摘Unger JM Gentry LR Grossman JE 0,,:1
19Randomized double-blind placebo-controlled trial of aeetyl-L-earnitine for the prevention of taxane- induced neuropathy in women undergoingadjuvant breast cancer therapy 显示文摘Hershman DL Unger JM Crew KD 2013J Clin Oncol2013,31,20:1
20Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma显示文摘Stiff P J Unger JM Cook JR 2013N Engl J Med2013,369,18:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费